 The research that's done here is really very much focused on translating fundamental discovery into humans and there's a focus on commercializing the work that's done. Internationally recognized for his clinical and research expertise, Dr. Rogers' commitment to quality care and clinical excellence is well recognized across the Texas Medical Center and far beyond. Prior to moving to Texas, he led prestigious heart transplant at heart failure programs at Duke and St. Louis based Washington University and his research focuses on one of THI's most well-known fields of innovation, left ventricular assist devices for patients with failing hearts. What is the next person prevention and management of patients because now THI has the patient care arm which which is very exciting and and really putting THI on a completely different level than before so could you talk to me a little bit about that? There's some very exciting things that are being done in our laboratories. We're developing new ventricular assist devices for patients who have congenital heart disease. We are working mightily in stem cells to try to understand how we might use them in a laboratory and then translate that into use in humans. So actually expanding that entire spectrum of care for patients who might benefit from stem cell therapies and a variety of other projects that are going on here including some really interesting drug development, some work on new catheters that are being used to treat patients who have electrical abnormalities of the heart. And so the fun part to think about is who do we bring into the Texas Heart Institute that adds to that portfolio of expertise and excellence. One of the very exciting things that we'll be working on is bringing in individuals who have a focus in clinical trials. There's a real opportunity for the Texas Heart Institute to leverage the data sources that we have access to to begin looking at outcomes research and to advance our position in health data sciences.